Back to Search
Start Over
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report.
- Source :
- Journal of Chemotherapy (Taylor & Francis Ltd); Jul2024, Vol. 36 Issue 4, p334-342, 9p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 1120009X
- Volume :
- 36
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Journal of Chemotherapy (Taylor & Francis Ltd)
- Publication Type :
- Academic Journal
- Accession number :
- 177943320
- Full Text :
- https://doi.org/10.1080/1120009X.2023.2276574